PDF) The histopathological approach to inflammatory bowel disease: A practice guide
ECCO Position Statement on the Use of Biosimilars for Inflammatory Bowel Disease—An Update
European Crohn´s and Colitis Organisation - ECCO - The Council of National Representatives
Untitled
Inflammatory Bowel Disease (IBD)
PDF) Oral azathioprine for steroid refractory severe ulcerative colitis | Gerassimos Mantzaris - Academia.edu
Palle BAGER | Clinical Nurse Specialist / Senior researcher / Associate Professor at Aarhus University | RN, MPH, PhD | Aarhus University Hospital, Århus | AUH | Department of Hepatology and Gastroenterology
Editorial_Board | Journal of Crohn's and Colitis | Oxford Academic
Editorial_Board | Journal of Crohn's and Colitis | Oxford Academic
European Crohn´s and Colitis Organisation - ECCO - The Council of National Representatives
PDF) Budesonide is superior to mesalazine in maintaining disease remission for patients with steroid-dependent Crohn's disease | Gerassimos Mantzaris - Academia.edu
Editorial_Board | Journal of Crohn's and Colitis | Oxford Academic
John TRIANTAFILLIDIS | Inflammatory Bowel Disease Unit, IASO General Hospital, Athens, Greece | Associate Professor, University of Medicine and Pharmacy, Iasi, Romania | IASO Hospital, Athens, Athens | IASO | IBD unit
European Crohn´s and Colitis Organisation - ECCO - Uncategorised
Editorial_Board | Journal of Crohn's and Colitis | Oxford Academic
Orally Administered Platinum Nanomarkers for Urinary Monitoring of Inflammatory Bowel Disease | ACS Nano
Julien KIRCHGESNER | Professor (Associate) | MD, PhD | Hôpital Saint-Antoine (Hôpitaux Universitaires Est Parisien), Paris | Service d'Hépato-Gastro-Entérologie - Nutrition
ECCO
iBDNEWS#1/14
WINTER
European Crohn´s and Colitis Organisation - ECCO - The Council of National Representatives
Γεράσιμος Μάντζαρης: «Ύφεση νόσου με ασφαλή και αποτελεσματικά φάρμακα» - Hellenic Medical Review
Clinical profiles of moderate and severe Crohn's disease patients and use of anti-tumor necrosis factor agents: Greek expert consensus guidelines. - Abstract - Europe PMC